A specific antidote for dabigatran: functional and structural characterization.
Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, Nar H, Litzenburger T.
Blood · journal article · DOI 10.1182/blood-2012-11-468207 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för dabigatran. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
21 hitsThe use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
Khoo TL, Weatherburn C, Kershaw G, Reddel CJ, Curnow J, Dunkley S.
Int J Lab Hematol · journal article · DOI 10.1111/ijlh.12005Hemopericardium and cardiac tamponade associated with dabigatran use.
Dy EA, Shiltz DL.
Ann Pharmacother · journal article; case reports · DOI 10.1345/aph.1r112Dabigatran: rational dose individualisation and monitoring guidance is needed.
Duffull SB, Wright DF, Al-Sallami HS, Zufferey PJ, Faed JM.
N Z Med J · journal articleAn indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S, Ansell J.
Thromb Haemost · comparative study; review; journal article · DOI 10.1160/th12-02-0093Dabigatran: a primer for neurosurgeons.
Fugate JE, Rabinstein AA, McBane RD, Lanzino G.
World Neurosurg · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.wneu.2012.06.019Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M, RE-LY Investigators.
Circulation · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1161/circulationaha.111.090464Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
Fellows SE, Rosini JM, Curtis JA, Volz EG.
J Emerg Med · journal article; case reports · DOI 10.1016/j.jemermed.2012.02.042Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.
Ferreira J, Ferreira D, Viana-Baptista M, Bettencourt P, Cernadas R, Crespo F.
Thrombosis · review-article; journal article · DOI 10.1155/2012/867121[The monitoring of application of dabigatran as a remedy of prevention of thromboembolic complications after hip joint arthroplasty].
Momot AP, Grigor'ev EV, Tsyvkina LP, Panov MIu, Merkulov IV.
Klin Lab Diagn · journal article; english abstractDabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).
Michaelis S, Marais A, Schrey AK, Graebner OY, Schaudt C, Sefkow M, Kroll F, Dreger M, Glinski M, Koester H, Metternich R, Fischer JJ.
J Med Chem · journal article · DOI 10.1021/jm3001339Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
Avecilla ST, Ferrell C, Chandler WL, Reyes M.
Am J Clin Pathol · journal article · DOI 10.1309/ajcpau7oqm0srpzqThromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
Garza R, Huo MH.
Expert Rev Cardiovasc Ther · review; journal article · DOI 10.1586/erc.12.15Anticoagulation therapy. Dabigatran and risk of myocardial infarction.
Eikelboom JW, Weitz JI.
Nat Rev Cardiol · comment; journal article · DOI 10.1038/nrcardio.2012.34Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran.
Stangier J, Feuring M.
Blood Coagul Fibrinolysis · research support, non-u.s. gov't; journal article · DOI 10.1097/mbc.0b013e32834f1b0cStroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Ali A, Bailey C, Abdelhafiz AH.
Age Ageing · comparative study; journal article · DOI 10.1093/ageing/afs017Determination of dabigatran in human plasma samples.
Harenberg J, Giese C, Marx S, Krämer R.
Semin Thromb Hemost · research support, non-u.s. gov't; review; journal article · DOI 10.1055/s-0031-1300947Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Författaruppgift saknas
Prescrire Int · comparative study; review; journal articleMyocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.
Circulation · randomized controlled trial; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1161/circulationaha.111.055970[Dabigatran and emergency operation on a peritonitis patient].
Ilmakunnas M, Louhimo J, Lassila R.
Duodecim · review; journal article; english abstractClinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairment.
Hariharan S, Madabushi R.
J Clin Pharmacol · controlled clinical trial; clinical trial, phase i; journal article · DOI 10.1177/0091270011415527